i
Johnson & Johnson/Janssen COVID-19 vaccine and cerebral venous sinus thrombosis with thrombocytopenia – update for clinicians on early detection and treatment
-
04/15/2021
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:Thursday, April 15, 2021
Time: 2:00 PM – 3:00 PM ET
This COCA Call will present the latest evidence on cerebral venous sinus thrombosis (CVST) with thrombocytopenia associated with the administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss what is known about CVST, the importance of early detection, and updated vaccine recommendations.
041521_slide.pdf
-
Content Notes:ACIP Influenza Vaccination Updates for the 2020–21 Season / Lisa Grohskopf -- Standards for Adult Immunization and Vaccination Guidance during the COVID-19 Pandemic / Tara Jatlaoui -- Flu vaccination planning and guidance for vaccination clinics in satellite, temporary, or off-site locations / Amy Parker Fiebelkorn.
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: